Astrazeneca PLC (AZN) closed at $186.43 on November 6, 2026, down 0.2% from the previous close, on volume of 2,423,980 shares (30-day average 3,100,461).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 15, 2026 | Calendar Call Ladder | 16-Oct-26170 C|15-Jan-27180 : 210 C | 47,016 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Key deals this week: PANW, META, OGI, CRM and more
Seeking Alpha News (Sat, 7-Nov 3:15 PM ET)
Democratic lawmakers seen probing Trump drug pricing deals come January
Seeking Alpha News (Fri, 6-Nov 12:13 PM ET)
Rhythm Pharmaceuticals gains on report of additional bidder
Seeking Alpha News (Fri, 6-Nov 11:06 AM ET)
Rhythm Pharmaceuticals jumps on report AstraZeneca made $10B bid
Seeking Alpha News (Wed, 4-Nov 4:13 PM ET)
DZ BANK AG Remains a Buy on AstraZeneca (AZN)
TipRanks (Wed, 4-Nov 2:35 AM ET)
How health care is on the ballot in the midterms
Seeking Alpha News (Tue, 3-Nov 12:13 PM ET)
AstraZeneca (AZN) Gets a Buy from Jefferies
TipRanks (Tue, 3-Nov 8:36 AM ET)
Goldman Sachs Remains a Buy on AstraZeneca (AZN)
TipRanks (Tue, 3-Nov 8:35 AM ET)
Pfizer (PFE) vs. AstraZeneca (AZN): Which Pharma Stock Offers a Better Dividend?
TipRanks (Tue, 3-Nov 8:05 AM ET)
Bernstein Remains a Buy on AstraZeneca (AZN)
TipRanks (Tue, 3-Nov 6:05 AM ET)
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Astrazeneca PLC trades on the NYSE stock market under the symbol AZN.
As of November 6, 2026, AZN stock price declined to $186.43 with 2,423,980 million shares trading.
AZN has a beta of -0.35, meaning it tends to be less sensitive to market movements. AZN has a correlation of 0.00 to the broad based SPY ETF.
AZN has a market cap of $289.02 billion. This is considered a Mega Cap stock.
Last quarter Astrazeneca PLC reported $16 billion in Revenue and $2.79 earnings per share. This beat revenue expectation by $195 million and exceeded earnings estimates by $1.35.
In the last 3 years, AZN traded as high as $212.71 and as low as $60.47.
The top ETF exchange traded funds that AZN belongs to (by Net Assets): PVAL, AVDE, DIHP, DFIC, PPH.
AZN has outperformed the market in the last year with a price return of +132.9% while the SPY ETF gained +10.8%. AZN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +17.8% and +8.7%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
AZN support price is $183.11 and resistance is $190.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZN shares will trade within this expected range on the day.
